• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的前列腺癌病例对照研究中 HOXB13 突变。

HOXB13 mutations in a population-based, case-control study of prostate cancer.

机构信息

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

出版信息

Prostate. 2013 May;73(6):634-41. doi: 10.1002/pros.22604. Epub 2012 Nov 5.

DOI:10.1002/pros.22604
PMID:23129385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3612366/
Abstract

BACKGROUND

Prostate cancer (PC) is the most frequently diagnosed non-skin malignancy in men in the Western world, yet few disease-associated mutations have been found. Recently, a low frequency recurring mutation in the HOXB13 gene was reported among both hereditary PC families and men from the general population.

MATERIALS AND METHODS

We determined the distribution and frequency of the G84E HOXB13 variant in 1,310 incipient PC cases and 1,259 age-mated controls from a population-based, case-control study of PC.

RESULTS

The G84E mutation was more frequent in cases than controls (1.3% vs. 0.4%, respectively), and men with the HOXB13 G84E variant had a 3.3-fold higher relative risk of PC compared with noncarriers (95% CI, 1.21-8.96). There was a stronger association between the G84E variant and PC among men with no first-degree relative with PC (OR, 4.04; 95% CI, 1.12-14.51) compared to men with a family history of PC (OR, 1.49; 95% CI, 0.30-7.50; P = 0.36 for interaction). We observed some evidence of higher risk estimates associated with the variant for men with higher versus lower Gleason score (OR, 4.13; 95% CI, 1.38-12.38 vs. OR, 2.71; 95% CI, 0.88-8.30), and advanced versus local stage (OR, 4.47; 95% CI, 1.28-15.57 vs. OR, 2.98; 95% CI, 1.04-8.49), however these differences were not statistically different.

CONCLUSIONS

These results confirm the association of a rare HOXB13 mutation with PC in the general population and suggest that this variant may be associated with features of more aggressive disease.

摘要

背景

在西方世界,前列腺癌(PC)是男性中最常见的非皮肤恶性肿瘤,但发现的与疾病相关的突变很少。最近,在遗传性 PC 家族和普通人群中的男性中,HOXB13 基因中出现了一种低频反复突变。

材料和方法

我们在一项基于人群的 PC 病例对照研究中,确定了 1310 例初发 PC 病例和 1259 例年龄匹配对照中 HOXB13 G84E 变体的分布和频率。

结果

突变在病例中比对照组更常见(分别为 1.3%和 0.4%),携带 HOXB13 G84E 变体的男性患 PC 的相对风险是未携带者的 3.3 倍(95%CI,1.21-8.96)。与有家族史的 PC 男性相比,无一级亲属患有 PC 的男性中,G84E 变体与 PC 的相关性更强(OR,4.04;95%CI,1.12-14.51)。与家族史为 PC 的男性相比(OR,1.49;95%CI,0.30-7.50;P=0.36 交互作用),我们观察到该变体与 Gleason 评分较高的男性风险估计值较高的一些证据(OR,4.13;95%CI,1.38-12.38 与 OR,2.71;95%CI,0.88-8.30)和晚期与局部阶段(OR,4.47;95%CI,1.28-15.57 与 OR,2.98;95%CI,1.04-8.49),但这些差异无统计学意义。

结论

这些结果证实了罕见的 HOXB13 突变与普通人群中 PC 的关联,并表明该变体可能与更具侵袭性疾病的特征相关。

相似文献

1
HOXB13 mutations in a population-based, case-control study of prostate cancer.基于人群的前列腺癌病例对照研究中 HOXB13 突变。
Prostate. 2013 May;73(6):634-41. doi: 10.1002/pros.22604. Epub 2012 Nov 5.
2
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.英国男性中 HOXB13 G84E 种系突变的流行率及其与前列腺癌风险、肿瘤特征和临床结局的相关性。
Ann Oncol. 2015 Apr;26(4):756-761. doi: 10.1093/annonc/mdv004. Epub 2015 Jan 16.
3
G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men.HOXB13基因中的G84E种系突变与波兰男性前列腺癌风险增加有关。
Pol J Pathol. 2019;70(2):127-133. doi: 10.5114/pjp.2019.87103.
4
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.基于人群的种系 HOXB13 G84E 突变与前列腺癌风险评估。
Eur Urol. 2014 Jan;65(1):169-76. doi: 10.1016/j.eururo.2012.07.027. Epub 2012 Jul 20.
5
Homeobox B13 G84E Mutation and Prostate Cancer Risk.同源盒 B13 G84E 突变与前列腺癌风险。
Eur Urol. 2019 May;75(5):834-845. doi: 10.1016/j.eururo.2018.11.015. Epub 2018 Dec 8.
6
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.HOXB13 基因中的 G84E 突变与波兰前列腺癌风险增加相关。
Prostate. 2013 Apr;73(5):542-8. doi: 10.1002/pros.22594. Epub 2013 Jan 17.
7
Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.丹麦接受根治性前列腺切除术男性中HOXB13 G84E突变的患病率及其与前列腺癌风险和侵袭性的相关性。
BJU Int. 2016 Oct;118(4):646-53. doi: 10.1111/bju.13416. Epub 2016 Feb 12.
8
Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.HOXB13 G84E 前列腺癌风险等位基因在接受根治性前列腺切除术治疗的男性中的流行率。
BJU Int. 2014 May;113(5):830-5. doi: 10.1111/bju.12522. Epub 2014 Mar 5.
9
Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.HOXB13 G84E携带者前列腺肿瘤的体细胞分子亚型分析。
Oncotarget. 2017 Apr 4;8(14):22772-22782. doi: 10.18632/oncotarget.15196.
10
G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.HOXB13基因中的G84E突变与前列腺癌风险密切相关:一项荟萃分析。
Tumour Biol. 2014 Feb;35(2):1177-82. doi: 10.1007/s13277-013-1157-5. Epub 2013 Sep 13.

引用本文的文献

1
HOXB13 and TFF3 can contribute to the prognostic stratification of prostate adenocarcinoma.HOXB13 和 TFF3 可有助于前列腺腺癌的预后分层。
Rom J Morphol Embryol. 2021 Jan-Mar;62(1):41-52. doi: 10.47162/RJME.62.1.04.
2
Single nucleotide polymorphisms in microRNA binding sites on the genes regulate carcinogenesis: An approach.基因上微小RNA结合位点的单核苷酸多态性调控致癌作用:一种方法。
Biochem Biophys Rep. 2021 Jul 22;27:101083. doi: 10.1016/j.bbrep.2021.101083. eCollection 2021 Sep.
3
Prostate cancer risk variants of the HOXB genetic locus.HOXB 基因座的前列腺癌风险变异体。
Sci Rep. 2021 May 31;11(1):11385. doi: 10.1038/s41598-021-89399-7.
4
Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease.鉴定增加前列腺癌风险并影响侵袭性疾病发展的生殖系基因变异。
Cancers (Basel). 2021 Feb 12;13(4):760. doi: 10.3390/cancers13040760.
5
Pathogenic Germline DNA Repair Gene and Mutations in Men With Metastatic Prostate Cancer.转移性前列腺癌男性患者的致病种系DNA修复基因及突变
JCO Precis Oncol. 2020 Mar 4;4. doi: 10.1200/PO.19.00284. eCollection 2020.
6
HoxB13 expression in ductal type adenocarcinoma of prostate: clinicopathologic characteristics and its utility as potential diagnostic marker.前列腺导管型腺癌中 HoxB13 的表达:临床病理特征及其作为潜在诊断标志物的应用。
Sci Rep. 2019 Dec 27;9(1):20205. doi: 10.1038/s41598-019-56657-8.
7
The Nuclear Protein HOXB13 Enhances Methylmercury Toxicity by Inducing Oncostatin M and Promoting Its Binding to TNFR3 in Cultured Cells.核蛋白 HOXB13 通过诱导抑瘤素 M 并促进其与培养细胞中的 TNFR3 结合来增强甲基汞的毒性。
Cells. 2019 Dec 23;9(1):45. doi: 10.3390/cells9010045.
8
Paralogous HOX13 Genes in Human Cancers.人类癌症中的同源HOX13基因
Cancers (Basel). 2019 May 20;11(5):699. doi: 10.3390/cancers11050699.
9
Association of homeobox B13 (HOXB13) gene variants with prostate cancer risk in an Iranian population.伊朗人群中同源框B13(HOXB13)基因变异与前列腺癌风险的关联。
Med J Islam Repub Iran. 2018 Oct 7;32:97. doi: 10.14196/mjiri.32.97. eCollection 2018.
10
Homeobox B13 G84E Mutation and Prostate Cancer Risk.同源盒 B13 G84E 突变与前列腺癌风险。
Eur Urol. 2019 May;75(5):834-845. doi: 10.1016/j.eururo.2018.11.015. Epub 2018 Dec 8.

本文引用的文献

1
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.基于人群的种系 HOXB13 G84E 突变与前列腺癌风险评估。
Eur Urol. 2014 Jan;65(1):169-76. doi: 10.1016/j.eururo.2012.07.027. Epub 2012 Jul 20.
2
Association between germline HOXB13 G84E mutation and risk of prostate cancer.胚系 HOXB13 G84E 突变与前列腺癌风险的关联。
J Natl Cancer Inst. 2012 Aug 22;104(16):1260-2. doi: 10.1093/jnci/djs288. Epub 2012 Jul 9.
3
A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.HOXB13 中的一个新种系突变与中国男性的前列腺癌风险相关。
Prostate. 2013 Jan;73(2):169-75. doi: 10.1002/pros.22552. Epub 2012 Jun 21.
4
Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.家族性前列腺癌中 HOXB13 G84E 种系突变的确认。
Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1348-53. doi: 10.1158/1055-9965.EPI-12-0495. Epub 2012 Jun 19.
5
Evaluation of HOXB13 as a molecular marker of recurrent prostate cancer.HOXB13 作为复发性前列腺癌的分子标志物的评估。
Mol Med Rep. 2012 Apr;5(4):901-4. doi: 10.3892/mmr.2012.769. Epub 2012 Jan 30.
6
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
7
Germline mutations in HOXB13 and prostate-cancer risk.HOXB13 种系突变与前列腺癌风险。
N Engl J Med. 2012 Jan 12;366(2):141-9. doi: 10.1056/NEJMoa1110000.
8
HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expression.HOXB13与雄激素受体共定位,以抑制雄激素刺激的前列腺特异性抗原表达。
Anat Cell Biol. 2010 Dec;43(4):284-93. doi: 10.5115/acb.2010.43.4.284. Epub 2010 Dec 31.
9
Association of hepsin gene variants with prostate cancer risk and prognosis.Hepsin 基因变异与前列腺癌风险和预后的关联。
Prostate. 2010 Jun 15;70(9):1012-9. doi: 10.1002/pros.21135.
10
Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.基于人群队列研究中, Gleason 4+3与Gleason 3+4前列腺癌病例在前列腺癌特异性死亡率及Gleason 7疾病方面的前列腺癌结局差异
J Urol. 2009 Dec;182(6):2702-7. doi: 10.1016/j.juro.2009.08.026.